It’s h ard to see what’s not there: A c ase of c ryptorchidism that e volved into i ntra-abdominal m etastatic s eminoma
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
It’s hard to see what’s not there: A case of cryptorchidism that evolved into intra-abdominal metastatic seminoma
1Midhir J. Patel, M.D., 1Kerry Thomas, M.D., 1Joseph R. Grajo, M.D., 2Michael Markow, M.D., 2Jon E. Finan, M.D., 1Rajendra P. Kedar, M.D.1University of South Florida Health - Morsani College of Medicine, Department of Radiology, Tampa, FL2Tampa General Hospital, Department of Pathology, Tampa, FL
Figures 1,2 & 3 - Coronal and axial CT images showing large anterior mesenteric mass ( ), large retroperitoneal mass ( ) and small soft tissue mass in the left lower abdomen ( ).
Figures 4 & 5 - Axial CT images showing approach for biopsies of anterior mesenteric and retroperitoneal masses.
Figure 6 – US image shows large heterogenous echogenic mass superior to the bladder that was also seen on CT as anterior mesenteric mass.
Figure 7 – US image shows absence of testes in the scrotum.
Testicular cancer is the most common malignancy in young males of age group 15-40 years, and is the leading cause of cancer-related morbidity and mortality in this age group. Testicular neoplasms are divided into two main categories, germ cell tumors (95%) and non-germ cell tumors (Leydig cell tumors, Sertoli cell tumors, lymphoma). The majority of germ cell tumors are seminomas, while the rest are classified as non-seminomas, comprised mainly of embryonal carcinoma, teratoma, yolk sac tumor, and choriocarcinoma.5
The most important risk factor for testicular germ cell tumor is undescended testes, or cryptorchidism.2,5 Cryptorchidism is the most common genitourinary anomaly that occurs in up to 3% of full-term and up to 30% of premature male infants. Treatment involves orchiopexy and if left untreated, increases the risk of infertility and testicular cancer.4 A meta-analysis of the literature has shown that a history of cryptorchidism increases the risk of testicular germ cell cancer by a factor of four.1Approximately 10% of all males with testicular germ cell neoplasm have a history of cryptorchidism.2,3 Other risk factors for testicular cancer include Klinefelter syndrome and family history.
Prompt diagnosis is essential in the prognosis of the patient because seminomas have high sensitivity to chemoradiation if treated at an early stage. Radiology plays a vital role in both the diagnosis and staging of seminoma. Ultrasound (US) represents the primary modality for evaluation of a testicular mass while computed tomography (CT) is the preferred method of staging. Due to the increased risk of testicular cancer with cryptorchidism, ultrasound is also the primary tool in the evaluation of infants with non-palpable testes to identify the location of the testes within the abdomen, inguinal canal, or subcutaneous tissues.2 We present a case of a young male who presented with abdominal pain. Diagnostic work-up discovered previously unknown cryptorchidism that evolved into metastatic seminoma seen as multiple abdominal masses on CT.
Other differential considerations in young males who present with abdominal masses include lymphoma, intestinal carcinoma, gasterointestinal stromal tumor (GIST) and desmoid tumor. Associated clinical signs may aid in identifying the correct diagnosis; but analysis of the tissue sample is the best way to differentiate between these entities, which usually requires radiographically-assisted intervention.
Testicular germ cell tumors account for approximately 1% of all cancers in males. The incidence of germ cell tumors has approximately doubled in the last 40 years but due to improvements in therapies, mortality has decreased.3 The association between cryptorchidism and germ cell tumors is well documented but the causative pathophysiology has not been established in the literature.2,3Early stage seminomas treated with chemotherapy have cure rate of over 90%. In patients with advanced disease, intense chemotherapy regimen with surgical resection of residual masses can provide 5-year survival rate of about 70%.5 Current clinical studies are striving to provide optimal management and long-term follow-up guidelines for patients with treated cryptorchidism who develop testicular malignancy.3
Untreated cryptorchidism leads to infertility and significantly increases the risk of germ cell malignancy. Newborns should properly be screened for this most common male genitourinary anomaly. US provides estimated 45% sensitivity and 78% specificity in accurately localizing non-palpable testes. Although not practical for screening, MRI can provide far greater sensitivity and specificity for localizing non-palpable testes.4 Orchiopexy is required to correct this anomaly and decrease associated morbidity. Early treatment has shown to decrease the risk of developing germ cell tumors but there are no published guidelines recommending an optimal time frame for intervention. Current literature is also not clear if early repair can reduce the risk to baseline.1
This case highlights the biological evolution of a congenital anomaly into a neoplastic process. Undiagnosed cases can present with acute clinical symptoms. Appropriate imaging and interventions are required to confirm the diagnosis for proper treatment. Diagnostic and interventional radiology services are essential to achieve this goal.
Figure 8 - H&E stain at 200 o.m. demonstrating classic-type seminoma arranged in nests with thin fibrous septae (pink), tumor-infiltrating lymphocytes, vacuolated cytoplasm and occasional mitotic figures (arrow).
Figures 9, 10 & 11 - Same field with membranous PLAP, nuclear Oct-4, and membranous CD117 positivity, confirming the diagnosis.